FdaApplication
ANDA 208430
Identifiers
- fda_app_no: ANDA208430
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMS INC |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LINAGLIPTIN; METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET;ORAL |
| LINAGLIPTIN; METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;850MG | TABLET;ORAL |
| LINAGLIPTIN; METFORMIN HYDROCHLORIDE | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;1GM | TABLET;ORAL |
3 products